精晶药业 (835033.OC)

+ 收藏

利润表(精晶药业)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2024年中报2023年年报2023年中报2022年年报2022年中报
上市前/上市后 上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 250,476,802.09443,315,932.61197,748,751.07320,367,551.09159,441,115.18
 营业收入(元) 250,476,802.09443,315,932.61197,748,751.07320,367,551.09159,441,115.18
二、营业总成本(元) 233,496,172.21418,868,860.52182,099,941.50335,323,993.36138,291,027.40
 营业成本(元) 208,210,790.71364,805,430.78156,656,537.61246,747,791.64108,063,868.16
 研发费用(元) 6,586,125.9814,607,241.377,397,192.0117,844,074.935,406,780.98
 营业税金及附加(元) 1,478,702.592,722,181.21996,336.013,107,777.721,677,549.55
 销售费用(元) 2,928,988.655,675,559.042,860,344.414,659,168.915,487,307.15
 管理费用(元) 9,008,534.6222,335,961.7510,056,445.9954,527,074.4514,637,346.78
 财务费用(元) 5,283,029.668,722,486.374,133,085.478,438,105.713,018,174.78
  其中:利息费用(元) 6,068,116.759,501,881.484,475,006.288,776,637.423,926,632.47
  其中:利息收入(元) 15,626.0546,530.3029,026.4663,534.4433,522.44
三、其他经营收益
 加:投资收益(元) -2,032,512.56---
 资产减值损失(元) -1,976,892.70515,838.69-5,251,881.53-12,091,258.53-52,249.36
 信用减值损失(元) 1,923,814.68-2,553,560.76258,466.67-3,995,789.51-713,913.34
 其他收益(元) 1,330,418.082,467,098.361,454,299.452,766,482.051,262,613.35
四、营业利润(元) 18,257,969.9426,908,960.9412,109,694.16-28,277,008.2621,646,538.43
 加:营业外收入(元) 10,378.50127,858.9515,934.60514,511.19-
 减:营业外支出(元) 572,160.002,206,279.17163,533.42220,049.11148,725.16
五、利润总额(元) 17,696,188.4424,830,540.7211,962,095.34-27,982,546.1821,497,813.27
 减:所得税费用(元) 2,773,562.453,836,563.551,389,067.66-5,447,939.643,666,399.63
六、净利润(元) 14,922,625.9920,993,977.1710,573,027.68-22,534,606.5417,831,413.64
(一)按经营持续性分类
  持续经营净利润(元) 14,922,625.99-10,573,027.68-22,534,606.5417,831,413.64
(二)按所有权归属分类
  归属于母公司股东的净利润(元) 14,940,436.3121,948,036.3110,575,589.05-22,102,222.1218,041,216.44
  少数股东损益(元) -17,810.32-954,059.14-2,561.37-432,384.42-209,802.80
 扣除非经常性损益后的净利润(元) 14,806,807.6926,778,492.198,338,041.33-24,703,909.7417,094,467.45
七、每股收益
 一、基本每股收益(元) 0.060.090.04-0.090.07
 二、稀释每股收益(元) 0.060.090.04-0.090.07
九、综合收益总额(元) 14,922,625.9920,993,977.1710,573,027.68-22,534,606.5417,831,413.64
 归属于母公司所有者的综合收益总额(元) 14,940,436.3121,948,036.3110,575,589.05-22,102,222.1218,041,216.44
 归属于少数股东的综合收益总额(元) -17,810.32-954,059.14-2,561.37-432,384.42-209,802.80
公告日期 2024-08-292024-04-022023-08-222023-04-272022-07-22
审计意见(境内) 标准无保留意见标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院